12/3
04:05 pm
exel
Exelixis to Webcast Virtual 2025 Research & Development (R&D) Day on Wednesday, December 10, 2025
Low
Report
Exelixis to Webcast Virtual 2025 Research & Development (R&D) Day on Wednesday, December 10, 2025
11/18
09:00 am
exel
Exelixis (NASDAQ:EXEL) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
Low
Report
Exelixis (NASDAQ:EXEL) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
11/10
01:43 pm
exel
Exelixis, Inc. (EXEL) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript [Seeking Alpha]
Low
Report
Exelixis, Inc. (EXEL) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript [Seeking Alpha]
11/7
02:55 pm
exel
Company News for Nov 6, 2025 [Yahoo! Finance]
Low
Report
Company News for Nov 6, 2025 [Yahoo! Finance]
11/6
09:40 pm
exel
Exelixis: The STELLAR Win Is A Mixed Bag, But Things Look Positive Still [Seeking Alpha]
Low
Report
Exelixis: The STELLAR Win Is A Mixed Bag, But Things Look Positive Still [Seeking Alpha]
11/6
04:05 pm
exel
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in November
Low
Report
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in November
11/6
12:48 pm
exel
Exelixis (NASDAQ:EXEL) had its price target raised by analysts at UBS Group AG from $35.00 to $40.00. They now have a "neutral" rating on the stock.
Low
Report
Exelixis (NASDAQ:EXEL) had its price target raised by analysts at UBS Group AG from $35.00 to $40.00. They now have a "neutral" rating on the stock.
11/5
02:21 pm
exel
Exelixis (NASDAQ:EXEL) had its price target raised by analysts at TD Cowen from $44.00 to $51.00. They now have a "buy" rating on the stock.
Low
Report
Exelixis (NASDAQ:EXEL) had its price target raised by analysts at TD Cowen from $44.00 to $51.00. They now have a "buy" rating on the stock.
11/5
01:31 pm
exel
Exelixis (NASDAQ:EXEL) had its price target raised by analysts at Morgan Stanley from $44.00 to $45.00. They now have an "overweight" rating on the stock.
Low
Report
Exelixis (NASDAQ:EXEL) had its price target raised by analysts at Morgan Stanley from $44.00 to $45.00. They now have an "overweight" rating on the stock.
11/5
12:12 pm
exel
Exelixis (NASDAQ:EXEL) was given a new $43.00 price target on by analysts at Stifel Nicolaus.
Low
Report
Exelixis (NASDAQ:EXEL) was given a new $43.00 price target on by analysts at Stifel Nicolaus.
11/5
11:41 am
exel
Exelixis (NASDAQ:EXEL) had its price target raised by analysts at HC Wainwright from $46.00 to $49.00. They now have a "buy" rating on the stock.
Medium
Report
Exelixis (NASDAQ:EXEL) had its price target raised by analysts at HC Wainwright from $46.00 to $49.00. They now have a "buy" rating on the stock.
11/5
11:02 am
exel
Exelixis (NASDAQ:EXEL) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Medium
Report
Exelixis (NASDAQ:EXEL) had its "buy" rating reaffirmed by analysts at Cowen Inc.
11/5
08:44 am
exel
Exelixis (NASDAQ:EXEL) was given a new $41.00 price target on by analysts at Barclays PLC.
Medium
Report
Exelixis (NASDAQ:EXEL) was given a new $41.00 price target on by analysts at Barclays PLC.
11/5
04:03 am
exel
Exelixis (NASDAQ:EXEL) had its "market perform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Medium
Report
Exelixis (NASDAQ:EXEL) had its "market perform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
11/4
05:01 pm
exel
Exelixis: Q3 Earnings Snapshot [Yahoo! Finance]
Medium
Report
Exelixis: Q3 Earnings Snapshot [Yahoo! Finance]
11/4
04:05 pm
exel
Exelixis Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Low
Report
Exelixis Announces Third Quarter 2025 Financial Results and Provides Corporate Update
11/3
08:08 am
exel
Exelixis (NASDAQ:EXEL) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.
Low
Report
Exelixis (NASDAQ:EXEL) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.
10/28
10:00 am
exel
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL
10/24
08:10 pm
exel
Exploring 3 High Growth Tech Stocks In The US Market [Yahoo! Finance]
Medium
Report
Exploring 3 High Growth Tech Stocks In The US Market [Yahoo! Finance]
10/23
10:00 am
exel
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL
10/22
06:57 am
exel
Exelixis (NASDAQ:EXEL) was upgraded by analysts at Leerink Partnrs from a "hold" rating to a "strong-buy" rating.
Low
Report
Exelixis (NASDAQ:EXEL) was upgraded by analysts at Leerink Partnrs from a "hold" rating to a "strong-buy" rating.
10/21
04:05 pm
exel
Exelixis to Release Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
Low
Report
Exelixis to Release Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
10/21
10:58 am
exel
Exelixis (NASDAQ:EXEL) was given a new $44.00 price target on by analysts at Morgan Stanley.
Low
Report
Exelixis (NASDAQ:EXEL) was given a new $44.00 price target on by analysts at Morgan Stanley.
10/21
10:50 am
exel
Exelixis (NASDAQ:EXEL) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $45.00 price target on the stock.
Low
Report
Exelixis (NASDAQ:EXEL) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $45.00 price target on the stock.
10/21
09:09 am
exel
Exelixis (NASDAQ:EXEL) had its price target lowered by analysts at Wells Fargo & Company from $36.00 to $30.00. They now have an "equal weight" rating on the stock.
Medium
Report
Exelixis (NASDAQ:EXEL) had its price target lowered by analysts at Wells Fargo & Company from $36.00 to $30.00. They now have an "equal weight" rating on the stock.